Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
Background: N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) has been identified as a member of m6A reader protein involving in many vital biological processes, whereas its...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2022-08-01
|
| Col·lecció: | Frontiers in Cell and Developmental Biology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fcell.2022.954214/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|